Equities

Pineapple Inc

PNPL:PKL

Pineapple Inc

Actions
  • Price (USD)0.065
  • Today's Change0.00 / 0.00%
  • Shares traded75.00
  • 1 Year change--
  • Beta--
Data delayed at least 15 minutes, as of Jun 05 2024 16:21 BST.
More ▼
Improved Notifications for Markets Data Alerts
Improved Notifications for Markets Data Alerts
Want push notifications sent directly to your devices for equity price changes and breaking news stories? Let us know here.
 
Existing alertsView our existing alerts
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Pineapple, Inc. procures and leases properties to licensed cannabis operators. The Company, through its wholly owned subsidiary, Pineapple Wellness, inc., provides nationwide hemp-derived cannabidiol (CBD) sales through online (Pineapplewellness.com) and in-store transactions. Its hemp CBD products are organically grown, non-GMO, don’t contain heavy metals or toxins and contain no heavy solvents. From plant to bottle, it offers lab-tested, quality CBD products that are natural and potent and contain less than 0.3% Tetrahydrocannabinol (THC). Through its other subsidiary, Pineapple Express Consulting Inc., it also offers cannabis business licensing and consulting services.

  • Revenue in USD (TTM)157.59k
  • Net income in USD376.69k
  • Incorporated2019
  • Employees--
  • Location
    Pineapple Inc10351 Santa Monica Blvd., Suite 420LOS ANGELES 90025United StatesUSA
  • Phone+1 (310) 877-7675
  • Websitehttps://pineappleinc.com/
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
China Pharma Holdings Inc6.42m-3.56m4.46m231.00--0.5021--0.6945-0.8352-0.83521.030.55960.38281.9314.1427,795.89-21.22-29.66-44.77-55.25-11.676.47-55.42-73.090.2523-11.340.261---13.48-10.6822.50---25.78--
Cingulate Inc0.00-22.50m4.47m13.00--1.12-----22.66-22.660.000.64190.00----0.00-355.56---1,198.96-------------33.880.0054-------33.14------
Geovax Labs Inc0.00-27.78m4.55m17.00--76.55-----14.42-14.420.000.02350.00----0.00-180.60-108.34-242.41-147.24-------1,842.93----0.00---100.00---85.20------
Artelo Biosciences Inc0.00-9.60m4.65m5.00--0.4873-----3.13-3.130.002.950.00----0.00-66.62---70.40--------------0.00------7.87------
Evoke Pharma Inc6.11m-7.13m4.72m4.00--1.35--0.773-1.83-1.831.280.40680.54290.51135.711,526,428.00-63.39-100.48-76.67-151.1096.01---116.76-480.525.35-19.250.5884--106.51--5.25------
Pineapple Inc157.59k376.69k4.75m--0.5834--12.4730.150.11140.11140.0028-0.03180.0388------9.28--53.43---412.55--239.03--0.00-----------611.10------
Theriva Biologics Inc0.00-19.04m4.82m21.00--0.1524-----1.15-1.150.001.990.00----0.00-32.65-36.95-37.33-40.16------------0.0064------8.37--95.91--
Azitra Inc572.70k-12.40m4.85m10.00--1.12--8.47-2.87-2.870.04920.15010.0977--11.5457,270.00-200.61---287.43-------2,053.34-----129.020.0085--141.55--6.02------
AccuStem Sciences Inc0.00-1.74m4.88m3.00---------0.1537-0.15370.00-0.23090.00----0.00-1,168.46--------------------------45.26------
Soligenix Inc699.21k-7.01m4.90m13.00--4.25--7.00-0.7395-0.73950.07250.0730.073--4.1753,785.38-73.17-75.40-2,448.34-154.329.4622.83-1,002.55-620.02----0.7959---11.54-30.6755.50------
Emmaus Life Sciences Inc28.46m-4.74m4.93m55.00------0.1734-0.0931-0.09310.3905-0.67730.63490.81849.36517,454.50-10.58------93.69---16.66--0.12490.1426-----10.77--33.37------
Lipella Pharmaceuticals Inc477.45k-4.74m4.94m5.00--1.79--10.35-0.7633-0.76330.07470.36380.1232--6.2595,490.00-122.37---146.33-------993.39------0.00--144.15---77.81------
MyMD Pharmaceuticals Inc0.00-7.07m4.96m9.00--0.2193-----5.53-5.530.0010.280.00----0.00-25.59-76.20-31.13-84.38--7.64---4,290.96----0.00------49.15------
Data as of Jun 05 2024. Currency figures normalised to Pineapple Inc's reporting currency: US Dollar USD
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.